SCTD Simplified CTD

SCTD, which stands for Simplified CTD (Common Technical Document), refers to a streamlined and simplified version of the Common Technical Document (CTD) format. The CTD is a globally recognized standard format for organizing and presenting information for the registration of pharmaceuticals and biologics. It provides a framework for compiling all the necessary data and documentation required by regulatory authorities for the approval of new drugs.

The CTD is a complex document structure that consists of five modules, each addressing specific categories of information. These modules are:

  1. Module 1: Administrative information: This module contains administrative and prescribing information, such as the drug's application form, regional specific requirements, and product information.
  2. Module 2: Summaries: This module includes summaries of the drug's quality, nonclinical, and clinical data. It provides an overview of the data contained in subsequent modules.
  3. Module 3: Quality: This module focuses on the pharmaceutical aspects of the drug, including its composition, manufacturing process, specifications, and stability data.
  4. Module 4: Nonclinical Study Reports: This module includes data from nonclinical studies, such as pharmacology, toxicology, and pharmacokinetics. It provides information on the drug's safety profile and potential risks.
  5. Module 5: Clinical Study Reports: This module contains data from clinical trials conducted on the drug, including information on study design, patient demographics, efficacy, safety, and statistical analysis.

While the CTD format provides a comprehensive framework for submitting regulatory documentation, it can be quite complex and time-consuming to compile. To simplify this process, the concept of SCTD was introduced. SCTD aims to reduce the complexity of the CTD format by focusing on the essential elements required for regulatory submissions.

SCTD eliminates some of the more detailed sections of the CTD that may not be directly relevant to the evaluation and approval of a drug. It streamlines the documentation process, making it more efficient and user-friendly for both applicants and regulatory authorities.

The specific details of the SCTD format may vary depending on the regulatory guidelines of different countries or regions. However, the key principle is to provide a concise and targeted submission that includes the most critical information necessary for the evaluation of the drug's quality, safety, and efficacy.

In summary, SCTD, or Simplified CTD, is a simplified version of the Common Technical Document (CTD) format. It aims to streamline the regulatory submission process by focusing on the essential elements required for evaluating and approving new drugs. By eliminating unnecessary sections, SCTD makes the documentation process more efficient and user-friendly while still meeting the regulatory requirements.